Skip to the card

Card 735 of 9932026-09-20 issue

Observed arrival · 2026-09-20

Sciatilief, With Nothing on the Label

sciatiilief.com Visit website
Editorial interest 78/100 Selection signal · not a rating of the site

Credibility concern recorded. The source reference remains available for verification and correction.

A buyer-warning page investigates a nerve-health capsule whose marketing discloses no ingredients, doses, or Supplement Facts panel.

Landing page captured for the 2026-09-20 issue.
For
People checking a nerve-support supplement before purchase
Worth noticing
The page reports zero named ingredients, zero disclosed doses, and a generic third-party review.

Field notes

The page builds its case by separating product marketing from a supplied third-party review, which it characterizes as a generic template rather than usable evidence. Its checklist records the absence of named ingredients, doses, and a Supplement Facts panel, while also preserving the product’s stated 30-capsule format and 60-day guarantee. It supplements the buyer warning with references to NIH, FDA, and FTC material and a list of symptoms requiring medical attention.

Observed signals

Read the marks

Editorial observations of this landing page, not a rating.

○OpenPublic substance visible
$PaidCommerce or pricing visible
◎NicheUnusually specific use
⚑RiskCredibility concern recorded

One card from the complete issue

Mahjongg With Footnotes

304,744 arrived 1,000 judged 993 catalogued Enter the complete issue
sciatiilief.com

Landing page observed 2026-09-20. The live site may have changed.